Pac Premier
Giving Guide
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Stellar Biotechnologies narrows net losses

By   /   Thursday, August 9th, 2018  /   Comments Off on Stellar Biotechnologies narrows net losses

    Print       Email
Stellar Biotechnologies reported earnings of $70,000 for its second quarter ended June 30 and narrowed its net losses 5 percent to $1.16 million. The company manufactures proteins derived from marine mollusks for use in immunotherapies out of Port Hueneme. It reported that expenses decreased for the quarter during which it raised $8.8 million, giving it…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email